Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Inorganic Chemistry|April 12, 2016
Synthesis, Characterization, and Photocatalytic H2-Evolving Activity of a Family of [Co(N4Py)(X)](n+) Complexes in Aqueous SolutionWarrick K C Lo, Carmen E Castillo, Robin Gueret, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 23, 2013
A randomized pilot trial of dietary modification for the chemoprevention of noninvasive bladder cancer: the dietary intervention in bladder cancer studyJ Kellogg Parsons, John P Pierce, Loki Natarajan, et al.
Inorganic Chemistry|June 13, 2015
Tetradecanuclear Iron(III)-Oxo Nanoclusters Stabilized by Trilacunary HeteropolyanionsMasooma Ibrahim, Ali Haider, Yixian Xiang, et al.
Inorganic Chemistry|July 12, 2012
Toward an iron(II) spin-crossover grafted phosphazene polymerRoss J Davidson, Eric W Ainscough, Andrew M Brodie, et al.
Pain Reports|February 7, 2022
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesiaAmanda Lillywhite, Stephen G Woodhams, Sara V Gonçalves, et al.
Journal of the Air & Waste Management Association (1995)|September 11, 2015
Middle- and Neighborhood-Scale Variations of PM10 Source Contributions in Las Vegas, NevadaJ C Chow, J G Watson, M C Green, et al.
Toxins|August 17, 2013
Deletion and gene expression analyses define the paxilline biosynthetic gene cluster in Penicillium paxilliBarry Scott, Carolyn A Young, Sanjay Saikia, et al.
European Journal of Human Genetics : EJHG|February 26, 2021
Heterozygous COL9A3 variants cause severe peripheral vitreoretinal degeneration and retinal detachmentBenjamin M Nash, Christopher J G Watson, Edward Hughes, et al.
BMC Cancer|December 19, 2019
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trialMichael B Jameson, Kirsten Gormly, David Espinoza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 7, 2013
A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox IIV J Harvey, K J Sharples, R J Isaacs, et al.
Pageof 30